Dr. Venkatesh BS: The Enigma of Hemophagocytic Lymphohistiocytosis
Dr Venkatesh BS, Transplant Surgeon at CareVue Health, posted on LinkedIn:
”When the Immune System Turns on Itself: The Enigma of HLH
Few conditions blur the line between inflammation and devastation like Hemophagocytic Lymphohistiocytosis (HLH), a hyperinflammatory syndrome where the immune system turns upon itself.
Originally described in the 1950s as “familial hemophagocytic reticulosis,” HLH is now recognized across all ages either genetic (primary) or acquired (secondary), often triggered by viral infections, malignancies or autoimmune flares.
Cytotoxic T cells and macrophages go rogue, releasing massive amounts of cytokines (IFN-γ, IL-6, TNF-α), leading to fever, cytopenias, hyperferritinemia and multi-organ injury.
The liver is a frequent target, sometimes culminating in acute liver failure (ALF).
Clinical Presentation: When Every Organ Suffers
HLH is the great masquerader.
- Persistent high fever unresponsive to antibiotics
- Hepatosplenomegaly, cytopenias, elevated ferritin (often >10,000!)
- Transaminitis, coagulopathy, hypertriglyceridemia, hypofibrinogenemia
- Neurological symptoms or acute liver failure may occur in advanced stages
For hepatologists and transplant teams, HLH presenting as fulminant hepatic failure is a diagnostic minefield often mistaken for viral or autoimmune hepatitis.
When HLH Meets Liver Failure
HLH-associated ALF is one of the most challenging diagnostic and therapeutic dilemmas.
When unresponsive to immunosuppressive therapy (dexamethasone, etoposide, ruxolitinib), liver transplantation (LT) becomes a potential life saving bridge, provided the cytokine storm has subsided and systemic inflammation is controlled.
Liver Transplant in HLH: The Tightrope
When to Consider Liver Transplant in HLH
- Fulminant hepatic failure
- Irreversible hepatic necrosis with recovery of systemic inflammation.
- Post infection or post immune HLH where the cytokine storm has been controlled.
- Post chemotherapy hepatic failure in malignancy associated HLH.
Timing is critical!! transplant too early, and the hyperinflammatory state destroys the graft; too late, and multi-organ dysfunction sets in.
Post-transplant care demands balancing immune suppression vs immune dysregulation:
- Minimize calcineurin inhibitors early; rely on steroids or targeted cytokine blockers.
- Monitor ferritin, IL-2 receptor, and viral markers for relapse.
- Consider emapalumab or ruxolitinib if hypercytokinemia recurs.
When timed right and tailored well, LT can achieve excellent outcomes, not just organ replacement but immune recalibration.
HLH teaches us a profound lesson:
The immune system, when unrestrained, can be both healer and destroyer and the art of transplant medicine lies in restoring that delicate balance.
Have you encountered HLH presenting as acute liver failure or post transplant immune dysregulation?
Would love to hear your thoughts.”

Stay informed with Hemostasis Today.
-
Jan 29, 2026, 05:22Aravind Palraj Draws a Comparison Between APS and Lupus Cerebritis
-
Jan 29, 2026, 05:09Edina Cenko on Expanding Cardiovascular Risk: From Ischaemia to Emerging Frontiers
-
Jan 29, 2026, 04:58Anna Randi Shares the Latest Episode of The VWF and Angiogenesis Story from Her Lab
-
Jan 29, 2026, 04:49Ruah Alyamany on Her Contribution to Establishing The Role of IgM in APS
-
Jan 29, 2026, 04:42Jecko Thachil on ‘Break Through’ Thrombosis Despite DOAC Use
-
Jan 28, 2026, 13:55Ney Carter Borges on Colchicine As 2ry Prevention in Atherosclerotic CVD
-
Jan 28, 2026, 13:35Louise St Germain Bannon Invites You to Submit Your Work to JTH and RPTH
-
Jan 28, 2026, 13:26Livia Stanger and Colleagues Link CS014 to in Vivo Thrombosis
-
Jan 28, 2026, 13:14Robert Campbell Congratulates Izabella Andrianova for Her Recent Publication in JTH
